BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34196087)

  • 1. Treatment outcomes and complications in FIGO stage IIIC and IVB endometrioid endometrial cancer patients presenting as nodal spreads following systematic lymphadenectomy and adjuvant therapy.
    Kong TW; Jo E; Son JH; Paek J; Chang SJ; Ryu HS
    J Obstet Gynaecol Res; 2021 Sep; 47(9):3322-3330. PubMed ID: 34196087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphadenectomy in women with endometrial cancer: aspiration and reality from a radiation oncologist's point of view.
    Foerster R; Kluck R; Arians N; Rieken S; Rief H; Adeberg S; Bostel T; Schlampp I; Debus J; Lindel K
    Radiat Oncol; 2015 Jul; 10():147. PubMed ID: 26179059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant Radiation Field Extent and Sites of Failure in Node Positive Endometrioid Endometrial Cancer.
    Yerramilli D; Chen YH; Venkatachalam V; Alban GM; Buscariollo DL; Cheng T; King MT; Pretz JL; Russo AL; Lee LJ
    Pract Radiat Oncol; 2021; 11(5):394-403. PubMed ID: 34015544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant combined-modality therapy for stage IIIC endometrioid and non-endometrioid endometrial cancer.
    Chapman BV; Swanick CW; Ning MS; Allen PK; Soliman PT; Westin SN; Pardeshi V; Broaddus RR; Lu KH; Jhingran A; Eifel PJ; Klopp AH
    Gynecol Oncol; 2019 Jul; 154(1):22-28. PubMed ID: 31109659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of Patients With Surgically and Pathologically Staged IIIA-IVB Pure Endometrioid-type Endometrial Cancer: A Taiwanese Gynecology Oncology Group (TGOG-2005) Retrospective Cohort Study (A STROBE-Compliant Article).
    Chen JR; Chang TC; Fu HC; Lau HY; Chen IH; Ke YM; Liang YL; Chiang AJ; Huang CY; Chen YC; Hong MK; Wang YC; Huang KF; Hsiao SM; Wang PH
    Medicine (Baltimore); 2016 Apr; 95(15):e3330. PubMed ID: 27082583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant docetaxel and carboplatin chemotherapy administered alone or with radiotherapy in a "sandwich" protocol in patients with advanced endometrial cancer: a single-institution experience.
    Lan C; Huang X; Cao X; Huang H; Feng Y; Huang Y; Liu J
    Expert Opin Pharmacother; 2013 Apr; 14(5):535-42. PubMed ID: 23480059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival impact based on the thoroughness of pelvic lymphadenectomy in intermediate- or high-risk groups of endometrioid-type endometrial cancer: A multi-center retrospective cohort analysis.
    Kim TH; Kim HS; Kim TJ; Chang SJ; Kim DY; Ryu SY; Kim BG; Kim YT; Bae DS; Ryu HS; Nam JH
    Gynecol Oncol; 2016 Jun; 141(3):440-446. PubMed ID: 27020700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential versus "sandwich" sequencing of adjuvant chemoradiation for the treatment of stage III uterine endometrioid adenocarcinoma.
    Lu SM; Chang-Halpenny C; Hwang-Graziano J
    Gynecol Oncol; 2015 Apr; 137(1):28-33. PubMed ID: 25666606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FIGO stage IIIC endometrial carcinoma: resection of macroscopic nodal disease and other determinants of survival.
    Bristow RE; Zahurak ML; Alexander CJ; Zellars RC; Montz FJ
    Int J Gynecol Cancer; 2003; 13(5):664-72. PubMed ID: 14675352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphadenectomy in Early-Stage Intermediate-/High-Risk Endometrioid Endometrial Cancer: Clinical Characteristics and Outcomes in an Australian Cohort.
    Farrell R; Dixon SC; Carter J; Webb PM
    Int J Gynecol Cancer; 2017 Sep; 27(7):1379-1386. PubMed ID: 30814240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multi-institutional analysis of sequential versus 'sandwich' adjuvant chemotherapy and radiotherapy for stage IIIC endometrial carcinoma.
    Onal C; Sari SY; Yildirim BA; Yavas G; Gultekin M; Guler OC; Akyurek S; Yildiz F
    J Gynecol Oncol; 2019 May; 30(3):e28. PubMed ID: 30887753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of adjuvant radiotherapy in FIGO stage IIIC endometrial carcinoma: Treatment outcomes and prognostic factors in 52 irradiated patients.
    Hsieh HY; Wang L; Lu CH; Lin JC; Chen CC
    J Formos Med Assoc; 2018 Jul; 117(7):613-620. PubMed ID: 28867455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.
    Benedetti Panici P; Basile S; Maneschi F; Alberto Lissoni A; Signorelli M; Scambia G; Angioli R; Tateo S; Mangili G; Katsaros D; Garozzo G; Campagnutta E; Donadello N; Greggi S; Melpignano M; Raspagliesi F; Ragni N; Cormio G; Grassi R; Franchi M; Giannarelli D; Fossati R; Torri V; Amoroso M; Crocè C; Mangioni C
    J Natl Cancer Inst; 2008 Dec; 100(23):1707-16. PubMed ID: 19033573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of contemporary chemotherapy in stage IIIC endometrial cancer: a histologic dichotomy.
    Bakkum-Gamez JN; Mariani A; Dowdy SC; Weaver AL; McGree ME; Martin JR; Keeney GL; Jatoi A; Gostout BS; Podratz KC
    Gynecol Oncol; 2014 Mar; 132(3):578-84. PubMed ID: 24434057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic significance of aortic lymph node metastasis in endometrial cancer: Potential implications for selective aortic lymph node assessment.
    Cosgrove CM; Cohn DE; Rhoades J; Felix AS
    Gynecol Oncol; 2019 Jun; 153(3):505-510. PubMed ID: 30935714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nodal metastasis in endometrial cancer.
    Willis G; Misas JE; Byrne W; Podczaski E
    Eur J Gynaecol Oncol; 2011; 32(3):259-63. PubMed ID: 21797112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SATEN III-Splitting Adjuvant Treatment of stage III ENdometrial cancers: an international, multicenter study.
    Kahramanoglu I; Meydanli MM; Taranenka S; Ayhan A; Salman C; Sanci M; Demirkiran F; Ortac F; Haidopoulos D; Sukhin V; Kaidarova D; Stepanyan A; Farazaneh F; Aliyev S; Ulrikh E; Kurdiani D; Yalcin İ; Mavrichev S; Akilli H; Sarı ME; Pletnev A; Aslan K; Bese T; Kairbayev M; Vlachos D; Gultekin M
    Int J Gynecol Cancer; 2019 Oct; 29(8):1271-1279. PubMed ID: 31481453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphadenectomy and prognosis for elderly females with stage I endometrioid endometrial cancer.
    Zhao L; Li L; Ye Y; Han X; Fu X; Yu Y; Luo J
    Arch Gynecol Obstet; 2019 Sep; 300(3):683-691. PubMed ID: 31256231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining the survival benefit of adjuvant pelvic radiotherapy and chemotherapy versus chemotherapy alone in stages III-IVA endometrial carcinoma.
    Xiang M; English DP; Kidd EA
    Gynecol Oncol; 2019 Sep; 154(3):487-494. PubMed ID: 31257010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.